
Clinical Development · Recruitment
Enrolment That
Hits Its Numbers.
Digital-first, data-driven patient recruitment clinical trials programmes that accelerate enrolment and protect retention from first visit to last.

A Recruitment Model That Is Patient-First
Patient recruitment clinical trials teams face the same recurring problem: sites that enrol a fraction of their projected numbers, and timelines that slip month by month until the cost of delay becomes impossible to ignore. Our patient retention strategies begin where most CROs stop — with an honest feasibility assessment that identifies sites with genuine patient access. Clinical trial enrollment services built on real population data deliver enrolment rates that feasibility actually predicted. Our recruitment model is patient-first — the channels follow from understanding who the eligible patient is, where they are, and what will motivate them to participate.
- Feasibility built on real population data
- In-house digital recruitment campaigns
- Decentralised and hybrid patient access
- Formal Retention Plan before enrolment
Capabilities Across Every Stage
Three integrated disciplines, delivered by senior specialists as one accountable programme.
Recruitment Strategies
Clinical trial enrollment services from Vigilare Biopharma begin with epidemiological data, prescription databases, and disease registry analysis to build a site selection model based on actual patient flow. Trial recruitment CRO support covers the full site activation process — from feasibility questionnaires through contract execution and first patient screening. Patient enrollment optimization is achieved through continuous monitoring of screen failure rates by site and protocol criterion, with rapid intervention when a specific eligibility hurdle generates disproportionate failures. Recruitment analytics trials data is reviewed weekly and visible to sponsor teams in real time. Digital recruitment trials campaigns are designed and managed in-house, with A/B testing across creative and audience segments to drive cost-per-randomisation down throughout the study.
Digital & Site-Based Approaches
Site activation support is managed as a programme — not a task list. Every site has a named activation manager accountable for hitting agreed milestones, and delays are escalated before they compound into timeline risk. Decentralized trials recruitment expands the eligible patient pool for studies where geographic concentration is a genuine enrolment barrier. Clinical trial marketing materials are developed by writers with both health literacy expertise and regulatory compliance knowledge. Recruitment analytics trials performance data closes the loop between digital spend and enrolment outcome — budget is reallocated to what works.
Retention Optimization
Patient engagement strategies for retention begin at study design — reducing visit burden, offering flexible scheduling, and building patient-facing communications that help participants understand why their continued involvement matters. Retention programs trials evidence consistently shows that early contact, regular check-ins, and practical support are the interventions that move the needle on dropout rates. Our patient retention strategies are documented in a formal Retention Plan delivered alongside the Recruitment Plan before enrolment opens. For sponsors requiring global patient recruitment services USA EU APAC under a single strategy, we design campaigns and site activation programmes that are geo-targeted and locally compliant — clinical trial enrollment worldwide.
What You Receive
Tangible, submission-ready outputs — not status updates.
Recruitment Plan
Strategy covering site selection, digital channel design, timeline projections, and contingency triggers.
Site Feasibility Report
Data-driven assessment of each candidate site's patient access with quantified enrolment potential.
Digital Ad Campaigns
Compliant patient-facing advertising with A/B testing and performance optimisation.
Enrolment Metrics Dashboard
Real-time enrolment vs projections, screen failure rates, dropout rates, and site-level performance.
Why Sponsors Choose Vigilare
What sets this engagement apart from a generic vendor.
Data-Driven Feasibility
Feasibility assessments built on epidemiological data and prescription databases — not investigator self-reported patient estimates, which consistently overstate actual enrolment capacity.
Compliant Digital Campaigns
In-house digital campaign management with regulatory compliance review of all patient-facing materials before launch — covering FDA guidance, EU GDPR, and local advertising standards.
Decentralised Capability
Decentralised and hybrid recruitment capability including telemedicine pre-screening and home nursing visit coordination — expanding eligible patient access beyond traditional site networks.
Real-Time Analytics
Real-time enrolment analytics with weekly sponsor reporting — not monthly summaries of a month-old problem.
Configured to Your Model
We engage differently depending on the function you already have in place.
Rare Disease Sponsors
Challenge
Small, geographically dispersed patient populations that sites struggle to identify and enrol
How We Help
Registry-based site selection combined with digital patient-finding to maximise access to a limited eligible pool.
Sponsors with Delayed Studies
Challenge
Studies already behind enrolment projections needing rapid, targeted intervention
How We Help
Rapid feasibility review, root cause identification, and corrective strategies within weeks.
Phase II–III Programme Teams
Challenge
Multi-site studies requiring coordinated recruitment across countries and platforms
How We Help
Multi-channel recruitment programmes with site-level performance tracking and regular sponsor reporting.
Patient Recruitment, Answered.
01
How to recruit patients for clinical trials?
Effective patient recruitment for clinical trials combines site-based identification — where investigators screen their existing patient populations — with direct-to-patient outreach through digital advertising, patient advocacy organisations, disease registries, and social media. Site selection based on genuine patient access data is the single most important factor in predicting enrolment performance. Digital campaigns targeting specific disease communities extend reach beyond what site-based approaches can achieve alone.
02
How to improve trial retention?
Patient retention improves when burden is reduced and participants feel valued. Practical interventions — minimising unnecessary visits, offering travel reimbursement, providing home nursing options, sending regular study progress communications, and making scheduling genuinely flexible — consistently reduce dropout rates. Retention planning should be completed and funded before first patient enrolment, not designed reactively when dropout rates start rising.
Complete the Clinical Programme
Pair this with the other clinical functions that run alongside it — one team, one quality system.
Ready to accelerate enrolment?
Speak to our team about your programme requirements. We respond within one business day.